Verastem (VSTM) Other Non Operating Income (2019 - 2026)
Verastem (VSTM) recorded quarterly Other Non Operating Income of -$61000.0 in Q1 2026, down 103.76% quarter-over-quarter from $1.6 million in Q4 2025, and up 96.66% on a YoY basis from -$31018.1 in Q1 2025.
Verastem (VSTM) Other Non Operating Income (2019 - 2026) Analysis & Trends
Verastem's Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$61000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 96.66% year-over-year to -$61000.0; the TTM figure through Mar 2026 stood at $1.4 million (up 173.74% YoY), while the FY2025 annual figure was -$203000.0, down 65.04% from the prior year.
- Other Non Operating Income was -$61000.0 for Q1 2026 at Verastem, down from $1.6 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.6 million in Q4 2025 to a low of -$1.8 million in Q1 2025.
- Historically, Other Non Operating Income has averaged -$35058.8 across 5 years, with a median of -$24000.0 in 2024.
- Biggest YoY gain for Other Non Operating Income was 20187.5% in 2025; the steepest drop was 5986.67% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at -$7000.0 in 2022, then sank by 600.0% to -$49000.0 in 2023, then surged by 116.33% to $8000.0 in 2024, then surged by 20187.5% to $1.6 million in 2025, then tumbled by 103.76% to -$61000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$61000.0 (Q1 2026), $1.6 million (Q4 2025), and -$37000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61,000.00 |
| Dec 31, 2025 | 1.62 Mn |
| Sep 30, 2025 | -37,000.00 |
| Jun 30, 2025 | -110,000.00 |
| Mar 31, 2025 | -1.83 Mn |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | -77,000.00 |
| Jun 30, 2024 | -24,000.00 |
| Mar 31, 2024 | -30,000.00 |
| Dec 31, 2023 | -49,000.00 |
| Sep 30, 2023 | -13,000.00 |
| Jun 30, 2023 | -40,000.00 |
| Mar 31, 2023 | -7,000.00 |
| Dec 31, 2022 | -7,000.00 |
| Sep 30, 2022 | 20,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Dec 31, 2020 | -1.58 Mn |
| Mar 31, 2020 | 1.30 Mn |
| Dec 31, 2019 | 600,000.00 |